share_log
Moomoo 24/7 ·  Mar 28 11:30
Sutro Biopharma Shares Are Trading Higher After Oppenheimer Maintained Its Outperform Rating and $10 Price Target on the Stock. The Company Recently Reported 2023 Financial Results
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment